Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

EACR 2016 /
Polygenic risk and the targeted prevention of cancer

9th - 12th Jul 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 13.07.16
Views: 1370
Rating:

Prof Paul Pharoah - University of Cambridge, Cambridge, UK

Prof Pharoah speaks with ecancertv at EACR 2016 about mammographic screening, and the contributions of multiple genetic variations in determining risk.

He outlines how breast cancer is best positioned to incorporate polygenic risk assessment to reduce mortality, and how improved screening can help reduce the risks of overdiagnosis.

For more on breast cancer screening from the MINDACT trial, click here.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation